Inventor
BETTENCOURT BRIAN
US79 patents
⚠️ This page may combine multiple inventors who share the name “BETTENCOURT BRIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALNYLAM PHARMACEUTICALS INC
42 patentsUS10337010B2Jul 2, 2019
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC17 citations98
US9771591B2Sep 26, 2017
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC22 citations98
US9322018B2Apr 26, 2016
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC36 citations98
US11525138B2Dec 13, 2022
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC7 citations94
US11332743B2May 17, 2022
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC6 citations94
US11306314B2Apr 19, 2022
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC6 citations94
US11306316B2Apr 19, 2022
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC6 citations94
US11306315B2Apr 19, 2022
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC6 citations94
US10557139B2Feb 11, 2020
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC15 citations94
US10550390B2Feb 4, 2020
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC15 citations94
US9249415B2Feb 2, 2016
Complement component C5 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC24 citations94
US9783806B2Oct 10, 2017
TMPRSS6 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC16 citations93
US11130953B2Sep 28, 2021
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC8 citations92
US9850488B2Dec 26, 2017
Complement component C5 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC11 citations92
US9574192B2Feb 21, 2017
Serapina1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC14 citations92
US9133461B2Sep 15, 2015
Compositions and methods for inhibiting expression of the ALAS1 gene
ALNYLAM PHARMACEUTICALS INC19 citations92
US11866709B2Jan 9, 2024
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC3 citations86
US11840692B2Dec 12, 2023
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC3 citations84
US11834662B2Dec 5, 2023
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC3 citations84
US10934545B2Mar 2, 2021
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC6 citations84
US10913950B2Feb 9, 2021
TMPRSS6 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC5 citations84
US10465194B2Nov 5, 2019
Complement component iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC11 citations84
US10238749B2Mar 26, 2019
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC12 citations84
US10030244B2Jul 24, 2018
Serpina1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC6 citations84
US9879261B2Jan 30, 2018
Serpina1 siRNAs: compositions of matter and methods of treatment
ALNYLAM PHARMACEUTICALS INC10 citations84
US9701963B2Jul 11, 2017
Complement component C5 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC9 citations84
US9376680B2Jun 28, 2016
Serpinc1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC7 citations84
US9631193B2Apr 25, 2017
Compositions and methods for inhibiting expression of the ALAS1 gene
ALNYLAM PHARMACEUTICALS INC8 citations83
US9422562B2Aug 23, 2016
Compositions and methods for inhibiting expression of CD274/PD-L1 gene
ALNYLAM PHARMACEUTICALS INC8 citations83
US10370666B2Aug 6, 2019
Ketohexokinase (KHK) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC5 citations82
US12467051B2Nov 11, 2025
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC0 citations73
US11873491B2Jan 16, 2024
Complement component C5 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC2 citations73
US11419942B2Aug 23, 2022
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC2 citations73
US11198876B2Dec 14, 2021
Compositions and methods for inhibiting expression of TMPRSS6 gene
ALNYLAM PHARMACEUTICALS INC3 citations73
US11186842B2Nov 30, 2021
Complement component iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC4 citations73
US11162098B2Nov 2, 2021
Complement component C5 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC2 citations73
US11079379B2Aug 3, 2021
Methods of treating transthyretin (TTR) mediated amyloidosis
ALNYLAM PHARMACEUTICALS INC4 citations73
US10988768B2Apr 27, 2021
TMPRSS6 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC3 citations73
US10935917B2Mar 2, 2021
Serpina1 siRNAs: compositions of matter and methods of treatment
ALNYLAM PHARMACEUTICALS INC2 citations73
US10920223B2Feb 16, 2021
Serpina1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC2 citations73
US10814007B2Oct 27, 2020
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC3 citations73
US10683504B2Jun 16, 2020
Serpina1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC2 citations73
ALNYLAM PHARMACEUTICALS
1 patentDEFOUGEROLLES ANTONIN
1 patentBUMCROT DAVID
1 patentBETTENCOURT BRIAN
1 patentTOUDJARSKA IVANKA
1 patentHINKLE GREG
1 patentARROWHEAD RES CORPORATION
1 patentTRANSLATE BIO INC
1 patentShowing the top 50 of 79 patents by PatentIndex Score.